Schonfeld Strategic Advisors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,080
| Closed | -$60.4K | – | 1984 |
|
|
2025
Q1 | $60.4K | Buy |
10,080
+80
| +0.8% | +$479 | ﹤0.01% | 1933 |
|
|
2024
Q4 | $78K | Buy |
+10,000
| New | +$78K | ﹤0.01% | 1789 |
|
|
2024
Q1 | – | Sell |
-260,955
| Closed | -$1.53M | – | 1924 |
|
|
2023
Q4 | $1.53M | Buy |
260,955
+23,425
| +10% | +$138K | 0.01% | 824 |
|
|
2023
Q3 | $2.32M | Buy |
237,530
+39,805
| +20% | +$388K | 0.02% | 676 |
|
|
2023
Q2 | $2.34M | Sell |
197,725
-6,532
| -3% | -$77.3K | 0.02% | 699 |
|
|
2023
Q1 | $2.2M | Sell |
204,257
-1,143
| -0.6% | -$12.3K | 0.02% | 661 |
|
|
2022
Q4 | $2.37M | Buy |
205,400
+115,617
| +129% | +$1.34M | 0.02% | 755 |
|
|
2022
Q3 | $1.34M | Sell |
89,783
-118,817
| -57% | -$1.77M | 0.01% | 1080 |
|
|
2022
Q2 | $1.88M | Sell |
208,600
-32,700
| -14% | -$295K | 0.02% | 707 |
|
|
2022
Q1 | $1.81M | Sell |
241,300
-4,100
| -2% | -$30.7K | 0.02% | 728 |
|
|
2021
Q4 | $2.11M | Sell |
245,400
-26,800
| -10% | -$230K | 0.02% | 631 |
|
|
2021
Q3 | $2.29M | Sell |
272,200
-1,500
| -0.5% | -$12.6K | 0.02% | 614 |
|
|
2021
Q2 | $2.22M | Buy |
273,700
+68,990
| +34% | +$559K | 0.02% | 644 |
|
|
2021
Q1 | $1.8M | Buy |
204,710
+82,234
| +67% | +$721K | 0.02% | 667 |
|
|
2020
Q4 | $1.38M | Buy |
+122,476
| New | +$1.38M | 0.02% | 673 |
|
|
2018
Q2 | – | Sell |
-18,250
| Closed | -$811K | – | 783 |
|
|
2018
Q1 | $811K | Buy |
+18,250
| New | +$811K | 0.06% | 374 |
|